Tissue culture of urinary bladder tumor induced in a rat by N-butyl-N- (-4-hydroxybutyl) nitrosamine: establishment of cell line, Nara Bladder Tumor Ii
Toyoshima, K.; Ito, N.; Hiasa, Y.; Kamamoto, Y.; Makiura, S.
Journal of the National Cancer Institute 47(5): 979-985
1971
ISSN/ISBN: 0027-8874 PMID: 4941696 Document Number: 41926
Document emailed within 1 workday
Related Documents
Murase, T.; Kobayashi, O.; Aota, Y.; Mitsuta, H.; Koshikawa, T. 1983: Histological study of urinary bladder tumor: DNA of rat urinary bladder tumor caused by N-butyl-N-(4-hydroxybutyl) nitrosamine and that of human bladder tumor Hinyokika Kiyo. Acta Urologica Japonica 29(3): 303-310Geisinger, K.R.; Leighton, J.; Zealberg, J. 1978: Appearance of giant cells as a morphological response of rat bladder carcinoma cell line (Nara Bladder Tumor No. 2) to a continuous thermal gradient in tissue culture Cancer Research 38(5): 1223-1230
Ito, N.; Hiasa, Y.; Kamamoto, Y.; Makiura, S.; Okajima, E. 1970: Effects of 2,5-di-O-acetyl-D-glucaro-(1,4) (6,3)-dilactone (SLA) on experimental bladder tumor induced by N-butyl-N-(4-hydroxybutyl) nitrosamine Gan no Rinsho. Japan Journal of Cancer Clinics 16(10): 995-1001
Okajima, E.; Hiramatsu, T.; Okamoto, M.; Kihoin, K.; Ijuin, M.; Hirao, Y.; Ohara, S.; Babaya, K.; Kubota, K.; Samma, S.; Okamura, K.; Kaneko, Y.; Horii, Y.; Moriya, A. 1982: Effect of carboquone (esquinone) on the development of urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl) nitrosamine Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(5): 836-842
Becci, P.J.; Thompson, H.J.; Grubbs, C.J.; Squire, R.A.; Brown, C.C.; Sporn, M.B.; Moon, R.C. 1978: Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine Cancer Research 38(12): 4463-4466
Wei, M.; Wanibuchi, H.; Morimura, K.; Salim, E.I.; Moku, M.; Doi, K.; Mitsuhashi, M.; Masuda, C.; Shen, J.; Kinoshita, A.; Fukushima, S. 2004: Lack of preventive efficacy of FK228, a histone deacetylase inhibitor, against N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis in p53+/- and p53+/+ mice Anticancer Research 24(2b): 785-790
Nakanishi, K.; Hirose, M.; Ogiso, T.; Hasegawa, R.; Arai, M.; Ito, N. 1980: Effects of sodium saccharin and caffeine on the urinary bladder of rats treated with n-butyl-n-(4-hydroxybutyl)nitrosamine Gan 71(4): 490-500
Sakata, T.; Shirai, T.; Fukushima, S.; Hasegawa, R.; Ito, N. 1984: Summation and synergism in the promotion of urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine in F344 rats Gan 75(11): 950-956
Ohtani, M.; Kakizoe, T.; Nishio, Y.; Sato, S.; Sugimura, T.; Fukushima, S.; Niijima, T. 1986: Sequential changes of mouse bladder epithelium during induction of invasive carcinomas by N-butyl-N-(4-hydroxybutyl)nitrosamine Cancer Research 46(4 Part 2): 2001-2004
Kakizoe, T.; Kawachi, T.; Sugimura, T. 1979: Agglutination of bladder cells by concanavalin a during the early phase of treatment of rats with N-butyl-N-(4-hydroxybutyl)nitrosamine Cancer Research 39(9): 3353-3356
Hashimoto, Y.; Suzuki, E.; Okada, M. 1972: Induction of urinary bladder tumors in ACI-N rats by butyl(3-carboxypropyl)nitrosoamine, a major urinary metabolite of butyl-(4-hydroxybutyl)nitrosoamine Gan 63(5): 637-638
Ito, N.; Matayoshi, K.; Arai, M.; Yoshioka, Y.; Kamamoto, Y. 1973: Effect of various factors on induction of urinary bladder tumors in animals by N-butyl-n-(4-hydroxybutyl)nitrosoamine Gan 64(2): 151-159
Masuda, H.; Hirose, J.; Ohtawara, Y.; Suzuki, K.; Tajima, A.; Aso, Y.; Shomura, T.; Kawamura, K. 1985: Tissue concentration of 4'-O-tetrahydropyranyladriamycin in renal cell carcinoma and urinary bladder tumor Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(10): 1975-1979
Gravell, M.; Levine, P.H.; McIntyre, R.F.; Land, V.J.; Pagano, J.S. 1976: Epstein-Barr virus in an American patient with Burkitt's lymphoma: detection of viral genome in tumor tissue and establishment of a tumor-derived cell line (NAB) Journal of the National Cancer Institute 56(4): 701-704
Quentin, T.; Henke, C.; Korabiowska, M.; Schlott, T.; Zimmerman, B.; Kunze, E. 2004: Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression Anticancer Research 24(2b): 1011-1023
Suzuki, E.; Takeda, Y.; Mochizuki, M.; Hashimoto, Y.; Okada, M. 1981: Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat Gan 72(4): 539-546
Gregersen, B.; Mommsen, S.; Svanholm, H. 1999: Bladder tumor antigen test versus urinary cytology in patients with bladder tumors Ugeskrift for Laeger 161(14): 2071-2073
Dworák, O.; Janssen, D. 1989: Tumor-associated tissue eosinophilia in the urinary bladder: is it a real relationship? Applied Pathology 7(5): 294-297
Lin, C.W.; Lin, J.C.; Prout, G.R. 1985: Establishment and characterization of four human bladder tumor cell lines and sublines with different degrees of malignancy Cancer Research 45(10): 5070-5079
Oliveira, P.A.; Palmeira, C.; Colaço, A.; de la Cruz, L.F.P.; Lopes, C. 2006: DNA content analysis, expression of Ki-67 and p53 in rat urothelial lesions induced by N-butyl-N-(4-hydroxybutyl) nitrosamine and treated with mitomycin C and bacillus Calmette-Guérin Anticancer Research 26(4b): 2995-3004